Background Endoscopic resection is used for the management of dysplasia in ulcerative colitis (UC), but a subset of patients develop subsequent advanced neoplasia (AN), i.e., high-grade dysplasia and/or colorectal cancer, despite apparently complete resection with histologically clear margins. Current risk stratification relies predominantly on histopathological and procedural features, which does not capture underlying genomic field cancerization of morphologically normal mucosa. Objective To determine whether genomic alterations within histologically non-dysplastic resection margins are asso
Genomic alterations in histologically clear low grade dysplasia resection margins forecast advanced neoplasia in ulcerative colitis
calendar_today
September 11, 2026
person
Fisher, J., Brautigam, K., Grant, H. E., Mossner, M., Sakr, C., Al Bakir, I., Saunders, B., Suzuki, N., Wilson, A., Baker, A.-M., Hart, A. L., Graham, T. A.
domain
medrxiv